Chimerix Inc (NAS:CMRX)
$ 0.9905 -0.0595 (-5.67%) Market Cap: 88.78 Mil Enterprise Value: -63.91 Mil PE Ratio: 0 PB Ratio: 0.51 GF Score: 55/100

Q2 2022 Chimerix Inc Earnings Call Transcript

Aug 08, 2022 / 08:30PM GMT
Release Date Price: $2.36 (-11.94%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Chimerix Second Quarter 2022 Earnings Conference Call.

I would now like to introduce you to your host for today's call, Michelle LaSpaluto, Vice President of Strategic Planning and Investor Relations at Chimerix. Please proceed.

Michelle LaSpaluto
Chimerix, Inc. - VP of Strategic Planning & IR

Thank you, and good afternoon, everyone.

This afternoon, we issued a press release on our second quarter operating update. You can access this press release in our Investors section of our website. With me on today's call are President and Chief Executive Officer, Mike Sherman; Chief Medical Officer, Allen Melemed; Chief Financial and Business Officer, Mike Andriole; Chief Science Officer, Randall Lanier; and our Chief Technology Officer of Imipridones, Josh Allen.

Before we begin, I'd like to remind you that the statements made on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot